Litcius/Paper detail

Obestatin and Rosiglitazone Differentially Modulate Lipid Metabolism Through Peroxisome Proliferator-activated Receptor-γ (PPARγ) in Pre-adipose and Mature 3T3-L1 Cells

Beekanahalli G. Mallikarjuna, Uma V. Manjappara

2021Cell Biochemistry and Biophysics12 citationsDOI

Topics & Concepts

ObestatinRosiglitazoneEndocrinologyInternal medicineDownregulation and upregulationAdipocyteAdipogenesisLipid metabolismReceptorChemistryAdipose tissuePeroxisome proliferator-activated receptorGLUT4ThermogeninBiologyWhite adipose tissueGhrelinInsulinInsulin resistanceMedicineBiochemistryGeneAdipose Tissue and MetabolismPeroxisome Proliferator-Activated ReceptorsAdipokines, Inflammation, and Metabolic Diseases
Obestatin and Rosiglitazone Differentially Modulate Lipid Metabolism Through Peroxisome Proliferator-activated Receptor-γ (PPARγ) in Pre-adipose and Mature 3T3-L1 Cells | Litcius